At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
解鎖市場時間軸與訊號動態
過去 90 日內有 2,136 個訊號。
此公司進入各市場的次序 — 由最舊至最新
The Sequence podcast EP1: Inside the global genomics leader
The Sequence podcast EP1: Inside the global genomics leader
註冊以查看完整訊號動態
Illumina 的國際擴張與競爭對手的比較
Illumina你長條顯示所比較各公司之間的相對規模。
5 項指標| 公司 | 市場 | 新市場 | 動能 | 活動 | 擴張評分 |
|---|---|---|---|---|---|
 Illumina你 | 32 | 0 | -79% | 2.1k | 36 |
急速擴張 — 過去 90 日內開放了 146 個職位，較上一期上升 56%。 以 Engineering 為主，集中於 新加坡。
Mexico · 昨日
CRM Senior Business Systems Analyst
Greater Bengaluru Area · 昨日
Staff PLM Ops Analyst
Singapore · 昨日
Logistics Coordinator 2
整個技術架構共偵測到 51 項技術。
於 201 個市場進行 299 個活躍廣告活動。
進行中過去 90 日內有 7 則提及。
因美納在中國推出MiSeq i100 Series-CN,由本地製造基地生產,符合全球質量標準,支持科研、公共衛生及生物醫藥測序應用,提供更快交付與服務。
八月首個完整週將有來自AI、半導體、醫療保健、能源、消費、軟件、金融科技、旅遊和量子計算公司的重要財報,重點關注Palantir等市場重量級企業。
因美納推出以DRAGEN驅動的移動式生信分析解決方案,將高性能算力直接送達科研與臨床研究一線,解決數據本地化合規與部署效率挑戰。
解鎖已驗證電郵與直撥電話
免費 · 無需信用卡
關於 Illumina 業務、市場及增長訊號的快速解答。
